C. Tropé
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 8
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 5
- Oncology top 10%
- Peptidase Inhibition and Analysis 1
- Surgery top 10%
- Intraperitoneal and Appendiceal Malignancies 4
-
- Cervical Cancer and HPV Research 2
- Neuroendocrine Tumor Research Advances 1
-
- Sarcoma Diagnosis and Treatment 1
- Renal cell carcinoma treatment 1
C. Tropé
13 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Reproductive Medicine 947
- Obstetrics and Gynecology 392
- Oncology 391
- Surgery 492
- Cancer Research 105
Countries citing papers authored by C. Tropé
This map shows the geographic impact of C. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tropé more than expected).
Fields of papers citing papers by C. Tropé
This network shows the impact of papers produced by C. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tropé. The network helps show where C. Tropé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Tropé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 2 | |
| 2 | The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome. | 2011 | 2 |
| 3 | EORTC-GcG/NCIC-CTG Randomised trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer (OVCA) | 2008 | 46 |
| 4 | Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trialbreakdown → | 2003 | 885 |
| 5 | Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide. | 2000 | 2 |
| 6 | 1993 | 67 | |
| 7 | Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix. | 1993 | 9 |
| 8 | 1993 | 20 | |
| 9 | 1993 | 82 | |
| 10 | 1992 | 22 | |
| 11 | A PHASE II STUDY OF 5-FU/ CIS IN RECURRENT CERVICAL CANCER | 1990 | 1 |
| 12 | Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations. | 1987 | 28 |
| 13 | 1979 | 15 |
About C. Tropé
C. Tropé is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Hepatology, Surgery and Epidemiology, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (5 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Cervical Cancer and HPV Research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Renal cell carcinoma treatment (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Reproductive Medicine (947 citations), Obstetrics and Gynecology (392 citations), Oncology (391 citations), Surgery (492 citations) and Cancer Research (105 citations). C. Tropé has collaborated with scholars based in Norway, Sweden and Switzerland. Frequent co-authors include Gunnar B. Kristensen, Delaloye Jf, Mahesh Parmar, Andreas du Bois, Jonathan A. Ledermann, Sarah Wheeler, Gordon C. Jayson, Valter Torri, Nicoletta Colombo and Alan Lamont. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Clinical Nutrition, The Lancet and International Journal of Gynecology & Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.